In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...